Related Experiment Video
Updated: Feb 4, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Dominik Bieg1, Daniel Sypniewski2, Ewa Nowak2
1Department of Biotechnology and Genetic Engineering, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice, Poland, Jedności Street 8, 41-200, Sosnowiec, Poland. dominik.bieg@med.sum.edu.pl.
Purpose:
This study aimed at evaluating whether morin (a natural flavonoid and a known inhibitor of NF-κB) can sensitize ovarian cancer cells to cisplatin by decreasing the expression of galectin-3, which is an anti-apoptotic protein regulated by NF-κB transcription factor.
Methods:
To assess the possibility of augmentation the activity of cisplatin by morin, we studied the separate and the combined effect of morin and cisplatin on viability, proliferation, and apoptosis of TOV-21G (cisplatin-sensitive) and SK-OV-3 (cisplatin-resistant) ovarian cancer cells. We also analysed the effect of morin and cisplatin on galectin-3 expression at the mRNA and protein levels.
Results:
We demonstrated that morin possess antitumor activity against TOV-21G and SK-OV-3 ovarian cancer cells by reducing cell viability and proliferation as well as increasing the induction of apoptosis. Co-treatment of the cells with selected concentrations of morin and cisplatin, accordingly to specific treatment approaches, reveals a synergism, which leads to sensitization of the cells to cisplatin. During this sensitization, morin significantly reduces the expression of galectin-3 at the mRNA and protein level, regardless of the presence of cisplatin.
Conclusions:
Morin sensitizes TOV-21G and SK-OV-3 ovarian cancer cells to cisplatin, what is associated with a decrease of the expression of galectin-3.
Insights
Morin, a natural flavonoid, enhances cisplatin
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ovarian cancer remains a significant health challenge, often developing resistance to chemotherapy.
- Galectin-3, an anti-apoptotic protein, is implicated in cancer progression and chemoresistance.
- Nuclear factor-kappa B (NF-κB) is a transcription factor that regulates galectin-3 expression.
Purpose of the Study:
- To investigate if morin can sensitize ovarian cancer cells to cisplatin.
- To determine the role of galectin-3 in morin-mediated chemosensitization.
- To evaluate the combined effects of morin and cisplatin on ovarian cancer cell behavior.
Main Methods:
- Assessing the effects of morin and cisplatin on ovarian cancer cell viability, proliferation, and apoptosis.
- Analyzing galectin-3 expression at both mRNA and protein levels.
- Utilizing cisplatin-sensitive (TOV-21G) and cisplatin-resistant (SK-OV-3) ovarian cancer cell lines.
Main Results:
- Morin demonstrated intrinsic antitumor activity against both ovarian cancer cell lines.
- Co-treatment with morin and cisplatin exhibited synergistic effects, sensitizing cells to cisplatin.
- Morin significantly reduced galectin-3 expression at both mRNA and protein levels, independent of cisplatin.
Conclusions:
- Morin effectively sensitizes ovarian cancer cells to cisplatin.
- The chemosensitizing effect of morin is associated with the downregulation of galectin-3.
- Morin holds potential as an adjuvant therapy to overcome cisplatin resistance in ovarian cancer.
Related Concept Videos
Decreasing Function
Decreased Body Temperature
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Cell Specific Gene Expression
Cell Specific Gene Expression
Ovarian Cycle

